Viking Therapeutics, Inc.
GB ˙ LSE ˙ US92686J1060
29,87 US$ ↑0,55 (1,88%)
2026-06-04
DELAT PRIS
SecurityGB:0VQA / Viking Therapeutics, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Caption Management, LLC ownership in 0VQA / Viking Therapeutics, Inc.

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 0 shares of Viking Therapeutics, Inc. (GB:0VQA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 36,880 shares of Viking Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (0VQA) in the form of stock options. The firm currently holds call options representing 305,000 of underlying shares valued at $9,924,700 USD and put options representing 100,000 of underlying shares valued at $3,254,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0VQA / Viking Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VIKING THERAPEUTICS COM 92686J106 0 -36,880 -100.00 0 -100.00
2026-02-17 2025-12-31 13F VIKING THERAPEUTICS COM 92686J106 36,880 -70,920 -65.79 1,297 -54.20 0.0089
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM 92686J106 107,800 107,800 2,833 0.0221
2025-08-14 2025-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -25,000 -100.00 0 -100.00
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM 92686J106 25,000 0 0.00 604 -40.06 0.0058
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM 92686J106 25,000 -24,500 -49.49 1,006 -67.89 0.0095
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM 92686J106 49,500 -4,400 -8.16 3,134 9.66 0.0500
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM 92686J106 53,900 14,853 38.04 2,857 -10.75 0.0440
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM 92686J106 39,047 37,543 2,496.21 3,202 11,755.56 0.0486
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM 92686J106 1,504 -10,416 -87.38 28 -79.39 0.0004
2023-11-14 2023-09-30 13F VIKING THERAPEUTICS COM 92686J106 11,920 11,920 132 0.0020
2020-02-13 2019-12-31 13F VIKING THERAPEUTICS COM 92686J106 0 -45,000 -100.00 0 -100.00
2019-11-14 2019-09-30 13F VIKING THERAPEUTICS COM 92686J106 45,000 45,000 309 0.0161
2019-08-13 2019-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -30,000 -100.00 0 -100.00
2019-05-14 2019-03-31 13F VIKING THERAPEUTICS COM 92686J106 30,000 30,000 299 0.0165
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VIKING THERAPEUTICS COM Call 305,000 38.01 9,925 27.66 n/a n/a n/a
2026-02-17 2025-12-31 13F VIKING THERAPEUTICS COM Call 221,000 -75.76 7,775 -67.56 n/a n/a n/a
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM Call 911,900 379.69 23,965 375.76 n/a n/a n/a
2025-08-14 2025-06-30 13F VIKING THERAPEUTICS COM Call 190,100 -34.94 5,038 -28.61 n/a n/a n/a
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM Call 292,200 1,068.80 7,057 601.39 n/a n/a n/a
2025-02-14 2024-12-31 13F VIKING THERAPEUTICS COM Call 25,000 -90.33 1,006 -93.85 n/a n/a n/a
2024-11-14 2024-09-30 13F VIKING THERAPEUTICS COM Call 258,400 7.67 16,359 28.59 n/a n/a n/a
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM Call 240,000 -44.70 12,722 -64.25 n/a n/a n/a
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM Call 434,000 294.55 35,588 1,638.54 n/a n/a n/a
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM Call 110,000 266.67 2,047 516.57 n/a n/a n/a
2023-11-14 2023-09-30 13F VIKING THERAPEUTICS COM Call 30,000 -70.00 332 -79.52 n/a n/a n/a
2023-08-14 2023-06-30 13F VIKING THERAPEUTICS COM Call 100,000 0.00 1,621 -2.64 n/a n/a n/a
2023-05-15 2023-03-31 13F VIKING THERAPEUTICS COM Call 100,000 1,665 n/a n/a n/a
2021-05-17 2021-03-31 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F VIKING THERAPEUTICS COM Call 50,000 0.00 281 -3.10 n/a n/a n/a
2020-11-16 2020-09-30 13F VIKING THERAPEUTICS COM Call 50,000 0.00 290 -19.67 n/a n/a n/a
2020-08-14 2020-06-30 13F VIKING THERAPEUTICS COM Call 50,000 0.00 361 54.27 n/a n/a n/a
2020-05-15 2020-03-31 13F VIKING THERAPEUTICS COM Call 50,000 0.00 234 -41.79 n/a n/a n/a
2020-02-13 2019-12-31 13F VIKING THERAPEUTICS COM Call 50,000 -77.78 402 -74.01 n/a n/a n/a
2019-11-14 2019-09-30 13F VIKING THERAPEUTICS COM Call 225,000 1,547 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VIKING THERAPEUTICS COM Put 100,000 3,254 n/a n/a n/a
2026-02-17 2025-12-31 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F VIKING THERAPEUTICS COM Put 76,900 2,646.43 2,021 2,629.73 n/a n/a n/a
2025-08-14 2025-06-30 13F VIKING THERAPEUTICS COM Put 2,800 -93.00 74 -92.34 n/a n/a n/a
2025-05-15 2025-03-31 13F VIKING THERAPEUTICS COM Put 40,000 966 n/a n/a n/a
2024-08-14 2024-06-30 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F VIKING THERAPEUTICS COM Put 612,500 182.26 50,225 1,143.81 n/a n/a n/a
2024-02-14 2023-12-31 13F VIKING THERAPEUTICS COM Put 217,000 70.87 4,038 187.40 n/a n/a n/a
2023-11-14 2023-09-30 13F VIKING THERAPEUTICS COM Put 127,000 163.49 1,406 79.90 n/a n/a n/a
2023-08-14 2023-06-30 13F VIKING THERAPEUTICS COM Put 48,200 781 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.